학술논문
A double blind, placebo controlled trial evaluating pegylated recombinant human megakaryocyte growth and development factor (MGDF) as an adjunct to induction and consolidation therapy inpatients with acute myeloid leukemia (AML).
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
00064971